Recent Biotech Financings: Clavis, Halozyme, Hyperion And GenScript
This article was originally published in The Pink Sheet Daily
Executive Summary
Taking advantage of the buzz associated with positive clinical trial data or enthusiasm for a business model, these four biotechs added to their coffers in recent weeks.